Back to Search
Start Over
What do we know about the renin angiotensin system and inflammatory bowel disease?
- Source :
-
Expert opinion on therapeutic targets [Expert Opin Ther Targets] 2022 Oct; Vol. 26 (10), pp. 897-909. Date of Electronic Publication: 2022 Dec 22. - Publication Year :
- 2022
-
Abstract
- Introduction: The renin-angiotensin system (RAS) is an important homeostatic pathway, with emerging evidence for the impact of its components on inflammation and fibrosis in gastrointestinal tissues. This review aims to review current knowledge of the physiological mechanism of RAS in inflammatory bowel disease (IBD), and potential therapeutic implications.<br />Areas Covered: An extensive online literature review including Pubmed, Medline, and Google Scholar was undertaken. Discussion on the components of the RAS, localization, and physiological functions in the gastrointestinal tract, preclinical, and clinical data in IBD, and the relation with SARS-Cov-2 are covered in this review.<br />Expert Opinion: RAS inhibition may have a role as anti-fibrotic adjunct therapy. Targeting the local gastrointestinal RAS with novel modes of delivery may be a target for future therapeutics for IBD, given the widespread availability and safety of current options as utilized in other diseases. Further insight into the mechanism and downstream effects of gastrointestinal ACE2 may lead to a better understanding of the pathogenesis of IBD.
Details
- Language :
- English
- ISSN :
- 1744-7631
- Volume :
- 26
- Issue :
- 10
- Database :
- MEDLINE
- Journal :
- Expert opinion on therapeutic targets
- Publication Type :
- Academic Journal
- Accession number :
- 36484415
- Full Text :
- https://doi.org/10.1080/14728222.2022.2157261